CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer

Gynecologic Oncology

Volumn 101, Issue 3, 2006, Pages 503-506

  Taskiran, Cagatay ^a   Aktas, Dilek ^a   Yigit Celik, Nilufer ^a   Alikasifoglu, Mehmet ^a   Yuce, Kunter ^a   Tunçbilek, Ergül ^a   Ayhan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adenocarcinoma; Cervical cancer; Cervical intraepithelial neoplasia; CYP1A1; Polymorphism

Indexed keywords

CYTOCHROME P450 1A1; ISOLEUCINE; VALINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 33646786102     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.11.018     Document Type: Article

References (29)

1. Parkin M.D., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
2. Preinvasive disease of the cervix. In: DiSaia P.J., and Creasman W.T. (Eds). Clinical gynecologic oncology (2002), Mosby 1-33
3. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J. Clin. 49 (1999) 33-64
4. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 49 (1989) 4677-4681
5. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87 (1995) 796-802
6. Invasive cervical cancer. In: DiSaia P.J., and Creasman W.T. (Eds). Clinical gynecologic oncology (2002), Mosby 53-112
7. Kawajiri K., Nakachi K., Imai K., Watanabe J., and Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol. 14 (1993) 77-87
8. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464 (2000) 65-76
9. Sugawara T., Nomura E., Sagawa T., Sakuragi N., and Fujimoto S. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int. J. Gynecol. Cancer 13 (2003) 785-790
10. Kim J.W., Lee C.G., Park Y.G., Kim K.S., Kim K., Sohn Y.W., et al. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88 (2000) 2082-2091
11. Goodman M.T., McDuffie K., Hernandez B., Bertram C.C., Wilkens L.R., Guo C., et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol. Oncol. 81 (2001) 263-269
12. Poulsen H.E., Taylor C.W., and Sobin L.H. Histological typing of female genital tract tumors. International histological classification of tumors vol. 13 (1975), World Health Organization, Geneva 15-18
13. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
14. Hayashi S.I., Watanabe J., Nakachi K., and Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res. 19 (1991) 4797
15. Jaiswal A.K., Gonzalez F.J., and Nebert D.W. Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Res. 13 (1985) 4503-4520
16. Lathrop G. Estimating genotype relative risks. Tissue Antigens 22 (1983) 160-166
17. Kawajiri K., and Fujii K.Y. P450 and human cancer. Jpn. J. Cancer Res. 82 (1991) 1325-1335
18. Prokopczyk B., Cox J.E., Hoffmann D., and Waggoner S.E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 89 (1997) 868-873
19. Prokopczyk B., Trushin N., Leszczynska J., Waggoner S.E., and El-Bayoumy K. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways. Carcinogenesis 22 (2001) 107-114
20. Garcia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366 (2005) 649-659
21. Hayashi S., Watanabe J., Nakachi K., and Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem. (Tokyo) 110 (1991) 407-411
22. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., and Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphism of cytochrome P4501A1 gene. FEBS Lett. 63 (1990) 131-133
23. Cascorbi I., Brocmoller J., and Roots I. A C4887A polymrophism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 56 (1996) 4965-4969
24. Mrozikiewicz P.M., Landt O., Cascorbi I., and Roots I. Peptide nucleic acid-mediated polymerase chain reaction clamping allows allelic allocation of CYP1A1 mutations. Anal. Biochem. 250 (1997) 256-257
25. Aktas D., Guney I., Alikasifoglu M., Yuce K., Tuncbilek E., and Ayhan A. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol. Oncol. 86 (2002) 124-128
26. Aktas D., Hascicek M., Sozen S., Ozen H., and Tuncbilek E. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet. Cytogenet. 154 (2004) 81-85
27. Murata M., Shiraishi T., Fukutome K., Watanabe M., Nagao M., Kubota Y., et al. Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan. Jpn. J. Clin. Oncol. 28 (1998) 657-660
28. Hung R.J., Boffetta P., Brockmoller J., Butkiewicz D., Cascorbi I., Clapper M.L., et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 24 (2003) 875-882
29. Esteller M., Garcia A., Martinez-Palones J.M., Xercavins J., and Reventos J. Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br. J. Cancer 75 (1997) 1385-1388